Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
Status:
Completed
Trial end date:
2007-03-20
Target enrollment:
Participant gender:
Summary
This study is an open-label study in healthy volunteers and in patients with Type 2 Diabetes
Mellitus to assess safety and tolerability parameters, the levels of GSK716155 in the
bloodstream after a single dose given at different injection sites, and the impact this
medication has on various substances in the blood. Assessments include ECGs, vital signs,
repeat blood sampling and monitoring of any side effects.